Preston Klassen is an officer of Regulus Therapeutics Inc.
Person profile
Roles
Regulus Therapeutics
Officer
Metacrine
Director
Address
La Jolla, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Regulus Therapeutics Inc.
17 Jan 24
4
Regulus Therapeutics Inc.
14 Aug 23
4
Regulus Therapeutics Inc.
12 Jun 23
3
Regulus Therapeutics Inc.
12 Jun 23
4
Metacrine, Inc.
24 Mar 23
3
Zura Bio Ltd
21 Mar 23
4
Metacrine, Inc.
27 Jan 23
4
Metacrine, Inc.
20 Apr 22
4
Metacrine, Inc.
18 Apr 22
4
Metacrine, Inc.
1 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jan 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.3 | 120,000 | 156.00 k | 120,000 |
10 Aug 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.36 | 225,000 | 306.00 k | 225,000 |
12 Jun 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.46 | 350,000 | 511.00 k | 350,000 |
23 Mar 23 | MTCR Metacrine | Common Stock | Grant | Dispose A | No | No | 0.47 | 842,211 | 395.84 k | 1,384,116 |
23 Mar 23 | MTCR Metacrine | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.47 | 842,211 | 395.84 k | 0 |